Idiopathic Thrombocytopenic Purpura (ITP) Clinical Trials

A listing of Idiopathic Thrombocytopenic Purpura (ITP) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 52 clinical trials
The DART Study- Daratumumab Treatment in ITP

A multicenter clinical, open-label total dose-escalating phase II study with safety run-in to explore the clinical activity, total dosage, and safety of daratumumab in adult ITP patients who have not responded adequately or relapsed after corticosteroids and at least one second-line therapy including rituximab and/or TPO-RA.

  • 0 views
  • 19 Apr, 2021
  • 6 locations
The PROLONG Trial - Rituximab Maintenance Therapy in ITP

This study is a two phase study that aims to evaluate if low-dose Rituximab maintenance therapy may prolong the the effect of Rituximab in immune thrombocytopenia.

dexamethasone
platelet count
autoimmune thrombocytopenia
prednisone
thrombocytopenia
  • 139 views
  • 26 Jan, 2021
  • 1 location
The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

adults with primary immune thrombocytopenia (ITP).

dexamethasone
autoimmune thrombocytopenia
thrombocytopenia
platelet count
atra
  • 17 views
  • 26 Jan, 2021
  • 1 location
Atorvastatin in Management of Newly Diagnosed ITP

The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of atorvastatin for the treatment of adults with immune thrombocytopenia

autoimmune thrombocytopenia
atorvastatin
platelet count
thrombocytopenia
  • 47 views
  • 24 Jan, 2021
  • 1 location
  • 0 views
  • 18 Feb, 2021
  • 1 location
Open-label Study Measuring Safety and Treatment Satisfaction in Adult Subjects With Chronic Immune Thrombocytopenia (ITP) After Switching to Avatrombopag From Eltrombopag or Romiplostim

Evaluate the safety and tolerability of avatrombopag given for 90 days after stopping treatment with eltrombopag or romiplostim.

avatrombopag
romiplostim
eltrombopag
thrombocytopenia
  • 0 views
  • 20 Jun, 2021
  • 4 locations
Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)

corticosteroid-resistant or relapsed immune thrombocytopenia (ITP) patients during the COVID-19 pandemic.

recombinant human thrombopoietin
eltrombopag
covid-19
autoimmune thrombocytopenia
corticosteroids
  • 0 views
  • 26 Jan, 2021
  • 1 location
Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)

treatment for corticosteroid-resistant or relapsed immune thrombocytopenia (ITP) during the COVID-19 pandemic.

recombinant human thrombopoietin
eltrombopag
covid-19
autoimmune thrombocytopenia
corticosteroids
  • 0 views
  • 25 Jan, 2021
  • 1 location
Proof-of-Concept: A Pilot Randomized Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia

Immune Thrombocytopenia (ITP) is a disorder resulting in impaired platelet production and enhanced destruction on the basis of autoantibody-mediated mechanisms. Patients with ITP are at

immunoglobulins
igiv
immunosuppressant
prednisone
remission
  • 11 views
  • 25 Jan, 2021
  • 1 location
The Safety Tolerability Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients

This is a randomized, double blinded, placebo-controlled phase Ib clinical trial in adult patients with immune thrombocytopenia. Cross-over treatment will be allowed during the study.

treatment regimen
anemia
splenectomy
thrombocytopenia
  • 7 views
  • 26 Jan, 2021
  • 1 location